CHLA-10Homo sapiens (Human)Cancer cell line
Also known as: CHLA10
AI Summary
No AI-generated summary available for this cell line.
Basic Information
| Database ID | CVCL_6583 |
|---|---|
| Species | Homo sapiens (Human) |
| Tissue Source | Thoracic lymph duct[UBERON:UBERON_0007644] |
Donor Information
| Age | 14 |
|---|---|
| Age Category | Pediatric |
| Sex | Female |
| Subtype Features | EWS-FLI |
Disease Information
| Disease | Primitive neuroectodermal tumor |
|---|---|
| Lineage | Bone |
| Subtype | Ewing Sarcoma |
| OncoTree Code | ES |
DepMap Information
| Source Type | Academic lab |
|---|---|
| Source ID | ACH-001029_source |
Haplotype Information (STR Profile)
Short Tandem Repeat (STR) profile for cell line authentication.
Amelogenin
X
CSF1PO
12
D13S317
12
D16S539
11
D18S51
12,14
D19S433
12,13
D21S11
28,29
D2S1338
20
D3S1358
15
D5S818
12
D7S820
9,10
D8S1179
10,13
FGA
23
TH01
7
TPOX
11
vWA
16
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines
Loading gene expression data...
Publications
Characterization of human cancer cell lines by reverse-phase protein arrays.
Liang H.
Cancer Cell 31:225-239(2017).
Sarcoma cell line screen of oncology drugs and investigational agents identifies patterns associated with gene and microRNA expression.
Harris E., Monks A., Morris J.
Mol. Cancer Ther. 14:2452-2462(2015).
Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines.
Jenabi J., Ji L.-Y., Triche T.J., Lawlor E.R., Reynolds C.P.
PLoS ONE 8:E80060-E80060(2013).
National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing.
Reynolds C.P.
Pediatr. Blood Cancer 56:239-249(2011).
Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
Batra S., Reynolds C.P., Maurer B.J.
Cancer Res. 64:5415-5424(2004).
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
Brodeur G.M., White P.S.
Cancer Res. 61:679-686(2001).
Systematic multi-omics profiling of Ewing sarcoma cell lines.";
Orth M.F.
Thesis PhD (2021); Ludwig Maximilians University of Munich; Munich; Germany.